Bloom Science, Inc.
Bloom Science, Inc. is a platform biotechnology company discovering and developing revolutionary new drugs targeting the gut-brain axis for the treatment and modification of diseases with high unmet need in neurology, immunology and oncology. Our proprietary platform developed by Bloom’s scientific co-founder Elaine Hsiao, PhD (UCLA) leverages genomic, gut microbiome, metabolomic and data analytics knowledge bases in combination with phenotypic screening to discover novel targets focused on the gut-brain axis and deliver the next generation of targeted therapeutics in areas with a clear path to deliver clinical innovation.
Company details
Find locations served, office locations
- Business Type:
- Technology
- Industry Type:
- Pharmaceuticals
- Market Focus:
- Nationally (across the country)
- Year Founded:
- 2018
About Us
We're a team of scientists, data-geeks and never-say-die entrepreneurs. We are rethinking how medicines are developed that can take advantage of our expanding insight into the role our gut microbiome plays in modulating key processes in the brain.